ResearcherNanfang HospitalNo recent work listed
Erbo Liang
Matched on OpenAlex author ID A5008937195.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 1
2020: 1 paper · 2021: 1 paper
Papers 2
- Correction to: MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. First author DOI 10.1038/s41388-021-01650-7↗
- MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. First author DOI 10.1038/s41388-020-01443-4↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Fachao Zhi · 2 shared papers, 2020–2021
- Paper Correction to: MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivi… DOI 10.1038/s41388-021-01650-7↗
- Paper MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity. DOI 10.1038/s41388-020-01443-4↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.